In a study published in Nature, Northwestern Medicine scientists have demonstrated that a gene is critical for the development of the ear’s outer hair cells, which has important implications for hearing loss treatments.
An experimental genetic inhibitor that could stave off Alzheimer’s disease has unintended consequences, but may represent a target for future drug development, according to a recent study.
An oral therapy called ibudilast significantly reduced the rate of brain tissue loss in patients with progressive multiple sclerosis, according to the results of a phase II trial.
Scientists have developed the first example of a bioresorbable electronic medicine: an implantable, biodegradable wireless device that speeds nerve regeneration and improves the healing of a damaged nerve.
Gemma Carvill, PhD, assistant professor of Neurology, has been named a recipient of the NIH Director’s New Innovator Award, which funds highly innovative research proposals with the potential to transform their field.
Northwestern has been awarded a $12 million, five-year grant from the NIH for a research center dedicated to advancing the genetic understanding of epilepsy.
Scientists have shown they can predict which chronic pain patients will respond to a placebo pill based on brain anatomy and psychological characteristics.
Northwestern Medicine scientists have identified how a type of RNA regulates genes over an unprecedented distance, during a critical process of embryonic brain development that affects adult seizure susceptibility.
Robert Kalb is moving Northwestern’s Les Turner ALS Center forward. Read the story in Northwestern Medicine magazine.